La enfermedad de Alzheimer: ¿Modelo de alfa-sinucleopatía?
Abstract
Carta el editor sobre el artículo:
Disbiosis intestinal en la enfermedad de Alzheimer
Downloads
References
Díaz GEF, Cabodevilla RCV. Disbiosis intestinal en la enfermedad de Alzheimer. Correo Científico Médico 2023 [citado 11/05/2023];27(1). Disponible en:
https://revcocmed.sld.cu/index.php/cocmed/article/view/4680
Shim KH, Kang MJ, Youn YC, An SSA, Kim S. Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease. Alzheimers Res Ther. 2022 [citado 20/05/2023];14(1):201. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/36587215
Ciaccioli G, Martins A, Rodrigues C, Vieira H, Calado P. A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration. PLoS One. 2013 [citado 12/05/2023];8(2):e55848. Disponible en:
https://www.ncbi.nlm.nih.gov/pubmed/23339603
Twohig D, Nielsen HM. α-synuclein in the pathophysiology of Alzheimer’s disease. Mol Neurodegener. 2019 [citado23/05/2023];14(1):23. Disponible en:
https://www.ncbi.nlm.nih.gov/pubmed/31186026
Brás IC, Outeiro TF. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells. 2021 [citado 15/04/2023];10(2):375. Disponible en:
https://www.ncbi.nlm.nih.gov/pubmed/33673034
Murros KE, Huynh VA, Takala TM, Saris PEJ. Desulfovibrio Bacteria Are Associated With Parkinson’s Disease. Front Cell Infect Microbiol. 2021 [citado 14/05/2023];11:652617. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/34012926
Published
How to Cite
Issue
Section
License
ACCESS AND DISTRIBUTION POLICY
All published articles are open access contributions, which are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is properly cited.
